LOCALIZATION OF MESSENGER-RNA FOR TISSUE INHIBITOR OF METALLOPROTEINASES-1 AND TYPE-IV COLLAGENASES/GELATINASES IN MONKEY HEPATOCELLULAR CARCINOMAS

被引:4
作者
LINDSAY, CK [1 ]
THORGEIRSSON, UP [1 ]
机构
[1] NCI,DIV CANC ETIOL,OFF DIRECTOR,TUMOR BIOL & CARCINOGENESIS SECT,BETHESDA,MD 20892
关键词
FIBROSIS; HEPATOCELLULAR CARCINOMA; METALLOPROTEINASES; TISSUE INHIBITORS OF METALLOPROTEINASES;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies of tissue inhibitors of metalloproteinases (TIMPs) suggest that one of their main functions is to inhibit metalloproteinase (MMP) activity and thus prevent tumor invasion by preserving extracellular matrix (ECM) integrity. In the present study we examined the distribution of transcripts for TIMP-1, MMP-2 and MMP-9 in monkey hepatocellular carcinoma tissues. In situ hybridization demonstrated elevated levels of TIMP-1 transcripts in fibrous tissue septa, tumor inflammatory infiltrate, tumor blood vessels and in expanded portal areas. However, elevated transcripts for MMP-2 and MMP-9 were found only in tumor inflammatory infiltrate. In lung metastasis high levels of TIMP-1 transcripts were found in the stromal cells surrounding necrotic tumor nodules, in tumor blood vessels, and in mesothelial cells, MMP-9 transcripts were elevated at the periphery of the necrotic tumor nodules. These findings suggest that TIMP-1 and type IV collagenases/gelatinases can be independently regulated in vivo and that TIMP-1 may have functions in ECM remodeling which are unrelated to inhibition of MMP activity.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 38 条
[1]  
ADAMSON RH, 1994, ENVIRON HEALTH PERSP, V102, P190
[2]  
Angerer L.M., 1992, IN SITU HYBRIDIZATIO, P15
[3]   RAS ONCOGENE MEDIATED INDUCTION OF A 92KDA METALLOPROTEINASE - STRONG CORRELATION WITH THE MALIGNANT PHENOTYPE [J].
BALLIN, M ;
GOMEZ, DE ;
SINHA, CC ;
THORGEIRSSON, UP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (03) :832-838
[4]   GROWTH-STIMULATION OF HUMAN KERATINOCYTES BY TISSUE INHIBITOR OF METALLOPROTEINASES [J].
BERTAUX, B ;
HORNEBECK, W ;
EISEN, AZ ;
DUBERTRET, L .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1991, 97 (04) :679-685
[5]  
CAMPBELL EJ, 1991, J IMMUNOL, V146, P1286
[6]  
CLAVEL C, 1992, B CANCER, V79, P261
[7]  
DOCHERTY AJP, 1985, NATURE, V315, P764
[8]   TRANSFORMING GROWTH-FACTOR BETA-MODULATES THE EXPRESSION OF COLLAGENASE AND METALLOPROTEINASE INHIBITOR [J].
EDWARDS, DR ;
MURPHY, G ;
REYNOLDS, JJ ;
WHITHAM, SE ;
DOCHERTY, AJP ;
ANGEL, P ;
HEATH, JK .
EMBO JOURNAL, 1987, 6 (07) :1899-1904
[9]  
EMONARD HP, 1992, CANCER RES, V52, P5845
[10]  
FUKADA Y, 1991, GASTROENTEROLOGICA J, V26, P37